A study shows that impaired chronotropic response after exercise treadmill testing is an effective, noninvasive tool to evaluate cardiac risk in patients with diabetes. Medscape Medical News
Results from ADVANCE-1, a study testing the novel anticoagulant apixaban in the prevention of venous thromboembolism, showed that the drug missed its primary end point, failing to meet statistical criteria for noninferiority when compared with enoxaparin. Heartwire
A randomized study shows that in patients with coronary artery disease, aerobic training combined with resistance training improves many outcomes. Medscape Medical News
